Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05512390
Title A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

diffuse large B-cell lymphoma

follicular lymphoma

chronic lymphocytic leukemia

Therapies

ABBV-319

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.